Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Should You Buy?

Shares of Elekta AB (OTCMKTS:EKTAY) saw unusually-high trading volume on Friday . Approximately 6,334 shares traded hands during mid-day trading, an increase of 134% from the previous session’s volume of 2,706 shares.The stock last traded at $6.33 and had previously closed at $6.74.

Elekta Stock Performance

The stock has a fifty day simple moving average of $6.11 and a 200-day simple moving average of $5.37. The stock has a market cap of $2.36 billion, a P/E ratio of 91.44 and a beta of 1.04. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 1.04.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings data on Wednesday, November 26th. The company reported $0.07 earnings per share for the quarter. The company had revenue of $427.85 million during the quarter, compared to analysts’ expectations of $436.91 million. Elekta had a return on equity of 12.14% and a net margin of 1.62%. On average, equities analysts expect that Elekta AB will post 0.36 earnings per share for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.